PRODUCT APPLICATIONS: Class I Applications: Currently meeting service standards. Class II Applications (meeting Workload Management eligibility criteria): Prioritized Class 2 applications are issued a decision within the […]
The ECHA RAC has officially adopted an opinion to IL1235 20-04-2026 Tonalide – ECHA RAC Opinion as Repr 1B adopted. This is a significant escalation from its previous classification. […]
The SCCS released its preliminary opinion on the safety of Heliotropin (also known as Piperonal) on April 15, 2026. This evaluation was triggered by a proposal to classify the […]
Health Canada’s Explanatory notes for drug establishments on the preparation of a site master file (GUI-0005), published in April 2026, provides a comprehensive framework for manufacturers to document their […]
This new Ad Standards Guidance provides a comprehensive framework for navigating environmental advertising in accordance with the Canadian Code of Advertising Standards, emphasizing that while “green” marketing is valuable, […]
Health Canada has finalized its regulatory approach for topical products containing human-derived exosomes, extracellular vesicles, and cell-conditioned media. Rather than labeling these substances as “inherent drugs,” Health Canada has […]
Our April 23, 2025 Regulatory Essentials reported the publication of A Guide to the environmental risk management authorities under the Food and Drugs Act. This guide highlights the principles, […]
March 25, 2026 an order adding 2-ethylhexyl-2-ethylhexanoate (CAS 7425-14-1) to Part 2 of Schedule 1 to the Canadian Environmental Protection Act (CEPA) was published in the Canada Gazette, Part II, Volume […]
On March 24th, an Order Amending the Non-domestic Substances List (NDSL) was published in the Canada Gazette, Part I, Volume 160, Number 14. This order adds 174 substances to the NDSL. […]
As noted in our last Regulatory Essentials, the Government of Canada has amended the Section 46 Notice for the Federal Plastics Registry, postponing reporting deadlines for Phases 2 and […]
